 |
[ login or create an account ]
|
|
[ login or create an account ]
|
News (209)
Politics (44)
Business (25)
National (22)
Sport (2)
Entertainment (1)
Health (115)
Fuseworks Media (209)
I'm looking for ...
Displaying 1 - 10 of 209 results
Subscribe to an RSS feed of this search 
Announcement in the budget of $191 million of new investment for medicines over the next two years is a start, but the fact that there is no confirmed additional investment beyond those two years is both a risk and concern, especially when compared to most other health packages in this year's bud
Successful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand patients and prescribers.
Pharmac welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control Agency) which analyses the access and efficacy of cancer medicines for solid tumours in adult patients in Aotearoa.
Medicines New Zealand stands in unity with both our sister associations and their member companies in Europe to support the sector's efforts to assist the people of Ukraine.
A new report, Access to Medicines 3 (AtoM 3) generated by IQVIA, the world's largest healthcare data science company, showed that New Zealand is consistently publicly funding fewer cost-effective modern medicines than Australia and making funding decisions at a slower pace.
Health Minister Andrew Little has released an interim report by an independent panel reviewing the national pharmaceuticals-buying agency Pharmac.
A new report - A Decade of Modern Medicines: An International Comparison produced by IQVIA, the world’s largest Healthcare Data Science Company, shows New Zealand ranks last out of 20 comparable OECD countries (the OECD20) for publicly funded access to modern medicines to treat a range of disea
Pharmac is working hard to limit the impact on over 1 million Kiwis who currently take funded API Consumer Brands (API) medicines, following their announcement that they are leaving the New Zealand market.
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe.
More education on medicinal cannabis needed for Kiwi prescribers One of the biggest barriers for Kiwis interested in medicinal cannabis is access to prescribers who understand the benefits of the products.
Voxy: Your Voice